Viewing Study NCT00079118


Ignite Creation Date: 2025-12-25 @ 4:32 AM
Ignite Modification Date: 2026-03-03 @ 1:15 PM
Study NCT ID: NCT00079118
Status: COMPLETED
Last Update Posted: 2016-12-13
First Post: 2004-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV breast cancer View
None recurrent breast cancer View
None male breast cancer View